Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
Ecopetrol
EC
US Stock MarketDetailed Quotes
AMPE Ampio Pharmaceuticals
- 0.004
- +0.001+38.46%
15min DelayTrading Dec 3 11:10 ET
4.09KMarket Cap0.00P/E (TTM)
0.004High0.003Low822Volume0.003Open0.003Pre Close2.30Turnover0.11%Turnover Ratio0.00P/E (Static)1.14MShares2.91052wk High0.00P/B2.76KFloat Cap0.00052wk Low--Dividend TTM766.22KShs Float3258.000Historical High--Div YieldTTM38.46%Amplitude0.000Historical Low0.002Avg Price1Lot Size
Ampio Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 59.47%-8.56M | 46.23%-2.31M | 90.66%-555K | 42.85%-3.4M | 53.46%-2.3M | -49.96%-21.13M | -15.93%-4.29M | -51.99%-5.94M | -155.46%-5.95M | -19.22%-4.94M |
| Net income from continuing operations | 47.16%-8.63M | 7.48%-2.05M | 80.83%-1.23M | 33.77%-1.37M | 29.42%-3.98M | 4.32%-16.34M | 64.33%-2.22M | -76.66%-6.41M | 41.77%-2.07M | -53.70%-5.64M |
| Operating gains losses | 100.97%56K | --0 | 99.49%-6K | --0 | 104.66%62K | -64.98%-5.76M | 87.45%-377K | -425.68%-1.17M | -2,387.93%-2.89M | -781.46%-1.33M |
| Depreciation and amortization | -88.36%122K | --0 | --0 | --0 | -53.44%122K | -4.20%1.05M | -30.42%183K | 31.94%347K | -6.57%256K | -10.88%262K |
| Other non cash items | -4,157.14%-284K | ---1K | --6K | --0 | ---289K | -91.25%7K | ---- | ---- | ---- | ---- |
| Change In working capital | 100.50%15K | 85.69%-293K | 177.68%630K | -79.24%-2.08M | 68.33%1.76M | -215.27%-2.97M | -172.69%-2.05M | -119.78%-811K | -215.87%-1.16M | 220.25%1.05M |
| -Change in receivables | ---920K | ---390K | --850K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in prepaid assets | -104.79%-51K | -101.15%-8K | -74.54%97K | 36.93%-432K | -56.42%292K | 279.43%1.06M | 534.55%698K | -25.00%381K | -22.32%-685K | 202.92%670K |
| -Change in payables and accrued expense | 131.60%1.25M | 107.04%193K | 80.19%-231K | 58.89%-185K | 271.28%1.47M | -221.37%-3.96M | -200.40%-2.74M | -36.69%-1.17M | -128.39%-450K | 299.50%397K |
| -Change in other current liabilities | -235.44%-265K | -1,660.00%-88K | -230.77%-86K | -223.08%-84K | 68.18%-7K | 11.24%-79K | 78.26%-5K | -8.33%-26K | -13.04%-26K | -15.79%-22K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 59.47%-8.56M | 46.23%-2.31M | 90.66%-555K | 42.85%-3.4M | 53.46%-2.3M | -49.96%-21.13M | -15.93%-4.29M | -51.99%-5.94M | -155.46%-5.95M | -19.22%-4.94M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 0 | 0 | -100.36%-111K | 0 | 0 | 0 | -104.13%-111K |
| Net common stock issuance | --98K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | 11.71%-98K | ---- | ---- | ---- | ---- | 95.58%-111K | --0 | --0 | --0 | 16.54%-111K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --0 | --0 | --0 | -100.36%-111K | --0 | --0 | --0 | -104.13%-111K |
| Net cash flow | ||||||||||
| Beginning cash position | -62.67%12.65M | -62.25%6.4M | -69.62%6.95M | -64.10%10.35M | -62.67%12.65M | 95.39%33.89M | -1.00%16.95M | 11.39%22.89M | 82.47%28.84M | 95.39%33.89M |
| Current changes in cash | 59.68%-8.56M | 46.23%-2.31M | 90.66%-555K | 42.85%-3.4M | 54.48%-2.3M | -228.36%-21.24M | -125.60%-4.29M | -73.21%-5.94M | -225.33%-5.95M | -227.82%-5.06M |
| End cash Position | -67.68%4.09M | -67.68%4.09M | -62.25%6.4M | -69.62%6.95M | -64.10%10.35M | -62.67%12.65M | -62.67%12.65M | -1.00%16.95M | 11.39%22.89M | 82.47%28.84M |
| Free cash flow | 59.47%-8.56M | 46.23%-2.31M | 90.66%-555K | 42.85%-3.4M | 53.46%-2.3M | -48.94%-21.13M | -15.93%-4.29M | -51.38%-5.94M | -155.46%-5.95M | -16.93%-4.94M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.